News
U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans — and removed one of the two vaccines available for young children. The new shots from Pfizer, ...
FDA approves new COVID vaccine shots for 2025-2026: Here’s who is eligible and what you need to know
Here’s a simple guide on who can get them, how they protect against current virus strains, and what to know about insurance.
LOS ANGELES (KABC) -- U.S. Food and Drug Administration officials describe full approval of the Pfizer COVID-19 vaccine for those 16 and older as a pivotal moment in the fight against the pandemic.
The Food and Drug Administration (FDA) on Wednesday approved the updated version of Pfizer’s and Moderna’s COVID-19 vaccines for this upcoming respiratory viral season, but limited the approval to ...
The US Food and Drug Administration approved updated Covid-19 vaccines but for a more limited group: adults age 65 and older ...
SAN FRANCISCO -- The FDA granted full approval of the Pfizer COVID-19 vaccine Monday for people 16 and older, paving the way for additional vaccine mandates. Experts wonder will California be next?
Amid increasing uncertainty over how the Trump administration would approach mRNA vaccines for the upcoming COVID-19 season, the FDA has approved Pfizer and BioNTech's updated shot. Consistent with ...
PHILADELPHIA (WPVI) -- The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, ...
21h
Zacks Investment Research on MSNPfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects
Pfizer PFE has strengthened its R&D pipeline through M&A deals and clinical trial success over the past decade. Pfizer has ...
BridgeBio Pharma (NASDAQ:BBIO) has accused its rivals, Pfizer (NYSE:PFE) and Alnylam (NASDAQ:ALNY), of using questionable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results